Accordingly, we identified a novel METTL3 TCM monomer inhibitor, isoforsythiaside, and demonstrated that it significantly inhibited the METTL3/EVL m6A axis, thereby preventing renal fibrosis. This evidence concerns the gene EVL and renal fibrosis.